Lakefront Biotherapeutics | GLPG - Trade Debtors


Lakefront Biotherapeutics reported EUR54.03M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
argenx SE USD 1.66B 458.83M Dec/2025
AstraZeneca USD 17.88B 1.17B Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Genmab DKK 1.17B 119M Dec/2025
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
GRIFOLS EUR 958M 106M Mar/2026
Hikma Pharmaceutical USD 1.08B 27M Dec/2025
Incyte USD 1.05B 27.09M Mar/2026
Merck EUR 4.81B 373M Mar/2026
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Novartis USD 9.6B 2.69B Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
UCB EUR 1.97B 54M Dec/2025
Vertex Pharmaceuticals USD 2B 56.7M Mar/2026